Omidubicel (former CordIn)
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, to Expedite Engraftment and Improve Transplant Outcome
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1/2
- Enrollment
- 37 patients (estimated)
- Sponsors
- National Heart, Lung, and Blood Institute (NHLBI)
- Tags
- Cord Blood, Monotherapy
- Trial Type
- Treatment
- Last Update
- 1 month ago
- SparkCures ID
- 1572
- NCT Identifier
- NCT03173937
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.